Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1095
0.00 (0.00%)
Jan 8, 2026, 2:03 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 134.42 million as of January 8, 2026. Its market cap has decreased by -39.17% in one year.
Market Cap
134.42M
Enterprise Value
152.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 134.42M, a decrease of -82.48%. That is a compound annual growth rate of -46.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 134.42M | 17.24% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.63T |
| Genmab | 133.42B |
| Coloplast | 126.88B |
| ALK-Abelló | 50.83B |
| Demant | 47.03B |
| H. Lundbeck | 41.54B |
| Zealand Pharma | 29.87B |
| Ambu A/S | 23.38B |